10:34 AM EDT, 06/30/2025 (MT Newswires) -- Kyverna Therapeutics ( KYTX ) said Monday it appointed Marc Grasso as chief financial officer, effective immediately.

Grasso succeeds Ryan Jones, who will become a strategic advisor to support the transition.

Grasso was most recently the CFO of clinical-stage biotech company Alector ( ALEC ) , Kyverna said.

Price: 3.25, Change: -0.03, Percent Change: -0.91